ClinVar Miner

Submissions for variant NM_000284.4(PDHA1):c.364G>A (p.Gly122Ser)

dbSNP: rs1555933643
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000497889 SCV000589489 likely pathogenic not provided 2015-10-15 criteria provided, single submitter clinical testing The G122S variant in the PDHA1 gene has been reported previously in a male patient with hypotonia, ventriculomegaly, infantile spasms and developmental delay; data showed this male individual to be heterozygous for G122S, which is suggestive of somatic mosaicism (Kutty et al., 2014). The G122S variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G122S variant is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (R119W, H121Q, R127W, R127Q) have been reported in the Human Gene Mutation Database in association with pyruvate dehydrogenase deficiency (Stenson et al., 2014), supporting the functional importance of this region of the protein. The G122S variant is a strong candidate for a pathogenic variant.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.